Oxford Asset Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-27,306	Closed	-$1.66M	–	458
2019 Q4	$1.66M	Buy	27,306 +13,346	+96%	+$813K	0.05%	534
2019 Q3	$572K	Buy	+13,960	New	+$572K	0.01%	1208